This newsletter provides information on recent publications in breast cancer research and upcoming conferences. It includes a summary of an editorial on the prognostic value of tumor-infiltrating lymphocytes in node-positive breast cancer. Brief summaries are given of recent literature on topics like dairy intake and breast cancer recurrence, decreasing late-stage breast cancer with mammography screening, and analyzing circulating tumor DNA to monitor metastatic breast cancer. Upcoming events like conferences are also listed.
Normalization of Tumor Microenvironment in Hepatocellular Carcinoma
Oral presentation made at the 2016 World Gastrointestinal Cancer Symposium in Barcelona by Eric Raymond MD, PhD at Saint-Joseph Hospital. This presentation comprehensively updates drugs targeting the microenvironment such as antiangiogenic agents such as VEGF/VEGFR inhibitors, stromal signaling inhibitors such as HGF/c-MET, FGF19/FGFR4, TGF-beta targeting agents and immunotherapy such as PD1/PDL1 and CTLA4 inhibitors in hepatocellular carcinoma. This presentation is aimed at targeting physicians, scientists, students, and experts in pharmas who are interested in drug development in this area of oncology.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
1. Senology Newsletter Page 1 of 3
Senology.org - Newsletter
International Senologic and Oncologic Scientific Community (ISOSC)
"Connecting specialists worldwide"
April 10, 2013
Editor-in-Chief: Gian Paolo Andreoletti, MD
Join us on LinkedIn, Twitter, Facebook, YouTube, ResearchGate, SlideShare, Flickr, and share comments.
Read Senology Newspaper daily
Senology collaborates with
Literature Selection
Kroenke CH et al.: "High- and Low-Fat Dairy Intake, Recurrence, and Mortality After Breast Cancer
Diagnosis", J Natl Cancer Inst. 2013 Mar 14. [Epub ahead of print]
Foca F et al.: "Decreasing incidence of late-stage breast cancer after the introduction of organized
mammography screening in Italy", Cancer. 2013 Mar 15 [Epub ahead of print]
Dawson SJ et al.: "Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer", N Engl J
Med. 2013 Mar 13. [Epub ahead of print]
Schindlbeck C et al.: "Comparison of circulating tumor cells (CTC) in peripheral blood and
disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients", J Cancer Res Clin
Oncol. 2013 Mar 23. [Epub ahead of print]
Harbeck N et al.: "Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American
Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision
making in node-negative breast cancer patients", Eur J Cancer. 2013 Mar 12 [Epub ahead of print]
Darby SC et al.: "Risk of ischemic heart disease in women after radiotherapy for breast cancer", N
Engl J Med. 2013 Mar 14;368(11):987-98
Donker M et al.: "Comparison of the sentinel node procedure between patients with multifocal and
unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: Identification rate and nodal
outcome", Eur J Cancer. 2013 Mar 19 [Epub ahead of print]
file://C:Documents and SettingsutenteDesktopSenology Newsletter.htm 09/04/2013
2. Senology Newsletter Page 2 of 3
Editorial
"Prognostic and predictive value of tumor-infiltrating lymphocytes in node-positive breast cancer",
Sherene Loi, Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer
Centre, East Melbourne, Victoria, Australia
""We and others have previously shown that an immune signal can influence prognosis and response to
treatment, particularly “immunogenic therapies” in specific breast cancer subtypes, such as those estrogen
receptor (ER)-negative and/or overexpressing the HER2/neu oncogene. To validate this further and determine
immunity could be a clinically relevant biomarker, we evaluated the association between quantity of tumor
infiltrating lymphocytes (TILs) in a breast cancer, prognosis and prediction of response to anthracyline
chemotherapy in a large clinical trial in over 2000 primary breast cancers and long term follow-up data. We
found that TILs were strongly associated with a good prognosis in the triple negative breast cancer (TNBC:
ER, PGR, and HER2-negative) subtype - even node positive TNBCs had an excellent survival if they were
observed to have high amounts of TILs at diagnosis (read more)".
(Commentary on: Loi S et al.: "Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a
Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the
Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98", J Clin
Oncol. 2013 Jan 22. [Epub ahead of print])
Questions and Answers
Breast Surgery Workshop Summary - The Center for Natural Breast Reconstruction, Mount Pleasant, SC,
USA
Fragments of History
1976 - Gianni Bonadonna (Milan, Italy): "Our data indicate that patients with potentially curable breast cancer
and with positive axillary lymph nodes at the time of mastectomy show a statistically significant reduction in
recurrence rate during the first 27 months after radical mastectomy when treated with cyclic prolonged
combination chemotherapy. At present, the advantage of CMF appears statistically evident in all subgroups of
patients" (Bonadonna G et al.: "Combination chemotherapy as an adjuvant treatment in operable breast
cancer ", N Engl J Med. 1976 Feb 19;294(8):405-10)
Calendar of Events
5th IMPAKT Breast Cancer Conference, May 2-4, 2013, Brussels, Belgium
Precision Medicines in Breast Cancer, May 9-10, 2013, London, UK
15th Milan Breast Cancer Conference, June 20-21, 2013, Milan, Italy
3rd World Congress on Cancer Science & Therapy, October 21-23, 2013, San Francisco, CA, USA - in
partnership with Senology
9th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 11-13,
Padova, Italy - under the Patronage of Senology
Update in Breast Imaging, 22-23 November, Ostend, Belgium
HEALTHCARE INDUSTRY NEWS
Bracco receives MHRA approval for expanded labeling of MultiHance
(gadobenate dimeglumine) in magnetic resonance imaging of the breast
Press release - Milan (Italy), March 11, 2013 - " Bracco receives MHRA approval for
expanded labeling of gadobenate dimeglumine in Magnetic Resonance Imaging of
the breast. - MultiHance, the highest relaxivity contrast agent for MRI of the central
nervous system, is now approved for breast MRI " (read more)
file://C:Documents and SettingsutenteDesktopSenology Newsletter.htm 09/04/2013
3. Senology Newsletter Page 3 of 3
Literature Selection
Rasmussn-Torvik LJ et al.: "Ideal Cardiovascular Health is Inversely Associated with Incident Cancer:
The Atherosclerosis Risk in Communities Study", Circulation. 2013 Mar 18. [Epub ahead of print]
Neef HP et al.: "Outcome after repeat resection of liver metastases from colorectal cancer", Int J
Colorectal Dis. 2013 Mar 7. [Epub ahead of print]
Park JH et al.: "The beneficial effect of palliative resection in metastatic colorectal cancer", Br J
Cancer. 2013 Mar 12 [Epub ahead of print]
Verhoven B et al.: "Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for
Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08", Int J Radiat
Oncol Biol Phys. 2013 Mar 5 [Epub ahead of print]
Bomers JG et al.: "MR Imaging-guided Focal Cryoablation in Patients with Recurrent Prostate
Cancer", Radiology 2013 Mar 22 [Epub ahead of print]
Mukozu T et al.: "Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and
Hepatocellular Carcinoma", Anticancer Res. 2013 Mar;33(3):1013-21
Yeon JS et al.: "Thyroid Nodules with Initially Nondiagnostic Cytologic Results: The Role of Core-
Needle Biopsy", Radiology 2013 Mar 22 [Epub ahead of print]
Discussion
"Intermittent versus continuous androgen deprivation in prostate cancer " - Share your opinion on
LinkedIn
Questions and Answers
Kidney Cancer Workshop Summary - with Robert Figlin, Cedars-Sinai’s Samuel Oschin Comprehensive
Cancer Institute, Los Angeles, CA, USA
Lung Cancer Workshop Summary - with Joel Neal, Stanford University, Stanford, CA, USA
Radiation Oncology Workshop Summary - with Matt Katz, Radiation Oncology Associates, Londonderry,
NH, USA
Melanoma Workshop Summary - with Alan Spatz, McGill University, Montréal, QC, Canada
Subscribe Unsubscribe Contact Back Issues
www.senology.org
file://C:Documents and SettingsutenteDesktopSenology Newsletter.htm 09/04/2013